Blood pressure enzyme reveals second job: Making sulfur rings for cellular antioxidants

Antioxidants such as vitamins C and E protect cells by neutralizing free radicals, such as reactive oxygen species, before they can damage genetic material or cell membranes. The science-journalism coverage adds useful context, while the strongest evidential footing still comes from the underlying data, papers or institutional documentation.

It is relevant because biology becomes more informative when an observed effect begins to look like a mechanism rather than an isolated pattern. The gap between identifying a correlation in biological data and understanding the causal chain that produces it is routinely underestimated, and the history of biomedical research is populated with associations that collapsed when the mechanism was sought and not found. A result that comes with a proposed mechanism, even a partial one, is more useful than a purely descriptive finding because it generates testable predictions that can narrow the hypothesis space. This article has been reviewed according to Science X's editorial process and policies. Katharina Maisenbacher / MPI-P Antioxidants such as vitamins C and E protect cells by neutralizing free radicals, such as reactive oxygen species, before they can damage genetic.

The body can also synthesize them with the help of various enzymes. Uladzimir Barayeu, a research group leader at the Max Planck Institute for Polymer Research in Mainz, has demonstrated a new mechanism that contributes to the body's production of.

The researchers have shown for the first time that eNOS has another function: The enzyme produces cyclooctasulfur (S₈), which serves as a storage form of elemental sulfur in cells. The researchers found particularly high concentrations of these "sulfur rings" in oxygen-dependent mitochondria, the powerhouses of the cell, as well as in lipid droplets, which.

Since mitochondria evolved from bacteria, the presence of S₈ within them may point to an ancient biochemical legacy. The international team's findings reveal for the first time a link between primordial sulfur chemistry and modern, oxygen-respiring mammalian cells.

The broader interest lies in whether the reported effect points toward a real mechanism and not merely a reproducible but unexplained association. Biology has learned from decades of biomarker failures that correlation, even robust correlation, is not a substitute for mechanistic understanding. A pathway that can be traced from molecular interaction to cellular response to organismal phenotype provides a far stronger foundation for intervention than a statistical association discovered in a large dataset, however well the statistics are done.

The study offers a new perspective on cells' internal antioxidant defenses. In the long term, this knowledge could open up new avenues for understanding diseases such as neurodegenerative disorders more fully and treating them more precisely.

Because this item comes through Phys. org Chemistry as science journalism, it should be treated as contextual reporting rather than primary evidence. Good science reporting can identify why a result matters, connect it to the wider literature and make technical work readable, but the decisive evidence remains in the original paper, dataset, mission release or technical record. That distinction is especially important when a story is later repeated by aggregators, because repetition increases visibility, not evidential strength.

The next step is to test whether the effect repeats across different methods, cell types, model organisms and experimental conditions. Reproducibility is the first test, but mechanistic dissection is the second, and a result that passes both has a substantially better chance of translating into something clinically or biotechnologically useful. The path from a laboratory finding to an applied outcome typically takes a decade or more, and most findings do not complete it; the current result sits at the beginning of that process.

Source